![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/matysova-tab-3.jpg)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
![Cancers | Free Full-Text | Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis Cancers | Free Full-Text | Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis](https://www.mdpi.com/cancers/cancers-13-00811/article_deploy/html/images/cancers-13-00811-g001.png)
Cancers | Free Full-Text | Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
![PDF] Prognostic Value of the Tumor Marker Index Based on Preoperative Serum Carcinoembryon-ic Antigen and Cytokeratin-19 Fragment Levels for Overall and Disease-Free Survival in Patients with Stage I Non-Small Cell Lung Cancer PDF] Prognostic Value of the Tumor Marker Index Based on Preoperative Serum Carcinoembryon-ic Antigen and Cytokeratin-19 Fragment Levels for Overall and Disease-Free Survival in Patients with Stage I Non-Small Cell Lung Cancer](https://d3i71xaburhd42.cloudfront.net/d2f4e9f1debc6a6bdbd7c11af1b651307f1e363b/4-Table3-1.png)
PDF] Prognostic Value of the Tumor Marker Index Based on Preoperative Serum Carcinoembryon-ic Antigen and Cytokeratin-19 Fragment Levels for Overall and Disease-Free Survival in Patients with Stage I Non-Small Cell Lung Cancer
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/matysova-graf-1-2.jpg)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
![Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway | Oncogenesis Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway | Oncogenesis](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41389-022-00396-5/MediaObjects/41389_2022_396_Figa_HTML.png)
Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway | Oncogenesis
![Cancers | Free Full-Text | The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer Cancers | Free Full-Text | The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer](https://pub.mdpi-res.com/cancers/cancers-14-05064/article_deploy/html/images/cancers-14-05064-ag.png?1666765625)
Cancers | Free Full-Text | The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer
![Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6602074/MediaObjects/41416_2004_Article_BF6602074_Fig1_HTML.gif)
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/matysova-tab-2.jpg)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/matysova-tab-1.jpg)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
![Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancer - IOS Press Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancer - IOS Press](https://content.iospress.com/media/tub/2021/43-1/tub-43-1-tub211504/tub-43-tub211504-g001.jpg)
Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancer - IOS Press
![Frontiers | Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value Frontiers | Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value](https://www.frontiersin.org/files/Articles/692788/fonc-11-692788-HTML-r1/image_m/fonc-11-692788-g001.jpg)